ClinicalTrials.gg
Drug

Granisetron clinical trials

Also written Kytril and Sancuso.

studies test it
63
open now
5
in phase 3
15
first study started
1996

How each study uses Granisetron is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Granisetron studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
29 Dec 1993 · KYTRIL · NDA 020239 (FDA, Drugs@FDA)
European Union
20 Apr 2012 · Sancuso · EMEA/H/C/002296 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Granisetron
36
granisetron hydrochloride
7
Sancuso® patch
6
Granisetron 1 Mg/mL Intravenous Solution
3
Granisetron Transdermal System
3

Brand

Kytril
9
Sancuso
6

Studies by the year they started

57 studies that test it; most in 2018 (6)

Studies that test Granisetron, by start year
YearStudies
19961
20041
20055
20063
20074
20081
20093
20101
20112
20123
20151
20162
20172
20186
20193
20202
20215
20223
20232
20245
20262

By phase

A phase 1/2 study counts in both.

Phase 1
9
Phase 2
15
Phase 3
15
Phase 4
17
No phase
8

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 20 · Other 43

Assiut University (6) · Kyowa Kirin Co., Ltd. (5) · Ain Shams University (2) · Teva Pharmaceuticals USA (2) · Roxane Laboratories (2) · LG Life Sciences (2) · Kyowa Kirin Pharmaceutical Development Ltd (2) · University of Colorado, Denver (1)

Often tested with

Tested in the same studies.

Ondansetron (8) · Palonosetron (5) · Dexamethasone (5) · Aprepitant (5) · Metoclopramide (4) · Meperidine (2) · Dolasetron (2) · Cyclophosphamide (2)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 2, 1 in phase 3

Studies that test Granisetron, phase 3 first.

Studies

Open first, then newest update. How each study uses Granisetron is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 63

See all 63 studies that test Granisetron →

Given beside what is tested · 12 — Granisetron is usual care or a partner of the new treatment
As the comparator · 9 — what is tested is compared with Granisetron

Codes

What other systems call Granisetron · ClinicalTrials.gg INT008616

  • MeSH (NLM) D017829GranisetronConfirmed ClinicalTrials.gov, Wikidata
  • UNII (FDA) WZG3J2MCOLGRANISETRONConfirmed FDA, Wikidata
  • RxNorm 26237Confirmed FDA, Wikidata
  • Wikidata Q596708granisetronConfirmed FDA, Wikidata
  • NCI Thesaurus C62031GranisetronConfirmed FDA, Wikidata
  • DrugBank DB00889One source Wikidata

Also registered as granisetron hydrochloride (UNII 318F6L70J8 · RxNorm 142149).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.